Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2001

View Archived Issues

Licensing opportunity from NIH: analogues of thalidomide as potential angiogenesis inhibitors

NIH licensing opportunity: methods and compositions for inhibiting HIV-coreceptor interactions

Antiinfluenza activity of BioCryst's cyclopentane neuraminidase inhibitor studied

Introgen's INGN-241 demonstrates potent antitumor properties in preclinical studies

Avant initiates second phase IIb trial of TP-10 in infants

Xenova reports Q1 highlights; merger with Cantab completed

Postprandial TG-lowering effects of NK-104 investigated in animal model

FM-VP4 highlighted at recent AHA conference as novel therapy for cardiovascular disease

Active metabolite of leflunomide proven to suppress eotaxin production

Therapeutic pipeline update provided by BioChem Pharma

Cannabinoid receptor agonist reduces IOP in monkeys with and without glaucoma

GSK designs and characterizes a new, high-affinity, selective PPARdelta agonist

Baxter seeks FDA approval to evaluate Neuprex for Crohn's disease

FDA clears phase II trials of novel immunosuppressive drug

Independent DSMB recommends continuation of phase III Theratope trial

Polypeptide with potential in gene therapy for immunodeficiency discovered at Hayashibara

Safety of mitoxantrone in MS patients highlighted at AAN meeting

Durect completes clinical portion of DUROS sufentanil phase II trial

MCH antagonists and use in obesity disclosed by Takeda

Potent and selective alpha1-adrenoceptor ligands reported by Lundbeck

Bivalent FVIIa/TF/FXa complex inhibitors

Shionogi prepares and tests new CB2 receptor ligands

Prostaglandin derivatives claimed by Taisho for inducing sleep, Rx of renal and cardiac disorders

Inhibitors of protein prenyltransferases identified by Dutch researchers

Company Profile: Conforma Therapeutics

NicOx nitric oxide-releasing steroid shows no blanching effect in phase I

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...